Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    ERYTHROCYTOSIS, FAMILIAL, 2
Show Display Options
Rank Status Study
1 Available Ruxolitinib for Chuvash Polycythemia
Condition: Erythrocytosis, Familial, 2
Intervention: Drug: Ruxolitinib

Study has passed its completion date and status has not been verified in more than two years.